TABLE 2.
In vitro susceptibilities of 12 selected P. aeruginosa isolates to 12 antimicrobial agents
| Isolate | MIC (μg/ml)a
|
Anti- biotype | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PP | CP | TZ | AT | IP | AK | NC | MC | OF | CI | PM | CR | ||
| A | >256 | >256 | >256 | 48 | >32 | >256 | >256 | >256 | >256 | >256 | >256 | >256 | I |
| B1 | >256 | >256 | >256 | 64 | 6 | 8 | 24 | >256 | >256 | >256 | >256 | >256 | II |
| D2 | 24 | 64 | 6 | 4 | 4 | 24 | 32 | >256 | 0.19 | 2 | 4 | 4 | III |
| D13 | >256 | 96 | 4 | 4 | 4 | 12 | >256 | >256 | 0.75 | 4 | 2 | 4 | IV |
| D16 | >256 | 128 | 3 | 4 | 3 | 12 | >256 | >256 | 4 | 16 | 2 | 4 | V |
| D19 | >256 | >256 | 128 | 24 | 6 | 64 | 12 | 2 | 0.094 | 0.75 | 64 | 64 | VI |
| E | >256 | >256 | >256 | >256 | >32 | 16 | >256 | 24 | >256 | >256 | >256 | >256 | VII |
| F | >256 | >256 | >256 | 48 | >32 | >256 | >256 | >256 | >256 | >256 | >256 | >256 | VIII |
| G1 | >256 | >256 | >256 | 96 | 3 | 16 | 16 | >256 | 0.19 | 1 | 128 | 64 | IX |
| H | >256 | >256 | 24 | 24 | >32 | 192 | >256 | >256 | >256 | >256 | 16 | 32 | X |
| I | >256 | >256 | 128 | 24 | >32 | 8 | 16 | >256 | >256 | >256 | 64 | 64 | XI |
| J | 48 | 96 | 48 | 12 | 2 | 24 | 96 | >256 | 2 | 24 | 24 | 32 | XII |
a
PP, piperacillin; CP, cefoperazone; TZ, ceftazidime; AT, aztreonam; IP, imipenem; AK, amikacin; NC, netilmicin; MC, minocycline; OF, ofloxacin; CI, ciprofloxacin; PM, cefepime; CR, cefpirome.